Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (301)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
27
2025
136
4.510
 Why?
Ovarian Neoplasms
24
2025
459
4.310
 Why?
Cancer Vaccines
13
2020
78
2.900
 Why?
Immunotherapy
13
2025
244
2.690
 Why?
Th17 Cells
3
2020
27
1.450
 Why?
Antigens, Neoplasm
11
2019
147
1.290
 Why?
Myxoma virus
2
2025
15
1.160
 Why?
Oncolytic Virotherapy
2
2025
21
1.160
 Why?
CD4-Positive T-Lymphocytes
8
2023
165
1.030
 Why?
Oncolytic Viruses
1
2025
13
0.960
 Why?
Uterine Cervical Neoplasms
13
2011
299
0.920
 Why?
Oncogene Proteins, Viral
7
2011
54
0.780
 Why?
Neoplasm Recurrence, Local
3
2020
643
0.730
 Why?
T-Lymphocytes, Regulatory
6
2011
84
0.700
 Why?
T-Lymphocytes, Cytotoxic
12
2013
66
0.680
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
14
0.640
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
78
0.590
 Why?
CD8-Positive T-Lymphocytes
11
2023
132
0.550
 Why?
Neoplasms
4
2019
1305
0.540
 Why?
Antibodies, Monoclonal
5
2019
481
0.540
 Why?
DNA-Binding Proteins
5
2007
429
0.530
 Why?
Interleukin-17
2
2020
35
0.520
 Why?
Adjuvants, Immunologic
4
2025
52
0.500
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
95
0.500
 Why?
Female
43
2025
28105
0.440
 Why?
Ascites
1
2014
32
0.440
 Why?
Cell Line, Tumor
14
2025
1436
0.430
 Why?
T-Lymphocytes
5
2017
340
0.430
 Why?
Immunologic Surveillance
2
2011
10
0.430
 Why?
Humans
54
2025
52336
0.390
 Why?
Cytokines
4
2014
625
0.390
 Why?
Carcinoma
2
2017
137
0.390
 Why?
Signal Transduction
3
2017
1716
0.380
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
43
0.370
 Why?
Immunotherapy, Active
1
2011
4
0.370
 Why?
Serine Endopeptidases
3
2009
50
0.360
 Why?
Cytotoxicity, Immunologic
7
2011
58
0.360
 Why?
Animals
17
2025
13523
0.330
 Why?
Adoptive Transfer
1
2009
29
0.320
 Why?
Immunotherapy, Adoptive
3
2005
167
0.300
 Why?
Interferon-gamma
7
2020
179
0.300
 Why?
Epitopes, T-Lymphocyte
3
2008
26
0.290
 Why?
Mice
10
2025
5965
0.280
 Why?
Lymphocyte Activation
3
2005
172
0.270
 Why?
Papillomavirus Vaccines
1
2007
69
0.260
 Why?
Herpesvirus 4, Human
2
2005
44
0.260
 Why?
Immunodominant Epitopes
2
2008
9
0.260
 Why?
Dependovirus
3
2011
103
0.230
 Why?
Virus Replication
1
2025
150
0.220
 Why?
HLA-A2 Antigen
3
2009
11
0.220
 Why?
Cell Transformation, Viral
1
2003
25
0.210
 Why?
Cell Line, Transformed
1
2003
75
0.200
 Why?
Poxviridae Infections
1
2022
4
0.200
 Why?
Poxviridae
1
2022
7
0.200
 Why?
Interferon Type I
1
2022
28
0.200
 Why?
Cystadenocarcinoma, Serous
5
2009
73
0.190
 Why?
Vaccination
4
2010
297
0.190
 Why?
Papillomavirus E7 Proteins
5
2011
32
0.190
 Why?
Disease-Free Survival
2
2020
460
0.190
 Why?
Interleukin-10
2
2017
84
0.190
 Why?
Receptor, erbB-2
4
2008
80
0.190
 Why?
Genes, MHC Class I
3
2008
11
0.180
 Why?
Flow Cytometry
8
2013
404
0.180
 Why?
Testis
2
2011
72
0.180
 Why?
Injections, Intradermal
1
2020
14
0.180
 Why?
Membrane Proteins
4
2011
340
0.180
 Why?
Macrophages
4
2022
378
0.170
 Why?
Immunity, Humoral
1
2020
23
0.170
 Why?
Coculture Techniques
3
2014
145
0.170
 Why?
Folate Receptor 1
1
2020
27
0.170
 Why?
Cell Movement
2
2019
277
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
236
0.170
 Why?
Carcinoma, Hepatocellular
1
2022
200
0.170
 Why?
Carcinoma, Lewis Lung
1
2019
10
0.160
 Why?
B-Lymphocytes
5
2017
185
0.160
 Why?
Melanoma, Experimental
1
2019
34
0.160
 Why?
Repressor Proteins
3
2011
156
0.160
 Why?
Self Tolerance
1
2019
1
0.160
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.160
 Why?
Liver Neoplasms
1
2022
332
0.150
 Why?
Transplantation, Autologous
1
2020
488
0.150
 Why?
Aged
12
2020
10109
0.150
 Why?
Cells, Cultured
6
2014
1589
0.140
 Why?
Cytotoxicity Tests, Immunologic
4
2005
26
0.140
 Why?
N-Acetylglucosaminyltransferases
1
2017
14
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2017
41
0.140
 Why?
Receptors, Notch
1
2017
28
0.140
 Why?
HLA Antigens
4
2006
56
0.140
 Why?
Middle Aged
16
2020
13014
0.130
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
102
0.130
 Why?
Neoplastic Stem Cells
1
2017
93
0.130
 Why?
Carcinoma, Papillary
3
2005
51
0.130
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.120
 Why?
Genetic Vectors
3
2011
128
0.120
 Why?
Poliovirus
2
2005
10
0.120
 Why?
Neoplasm Proteins
1
2017
334
0.120
 Why?
Adult
15
2011
14139
0.120
 Why?
Clinical Trials, Phase I as Topic
1
2015
25
0.120
 Why?
Adenocarcinoma
3
2004
405
0.120
 Why?
Galectin 3
1
2014
14
0.110
 Why?
Antigen Presentation
5
2009
26
0.110
 Why?
Kallikreins
2
2005
19
0.110
 Why?
Neoplasm Invasiveness
3
2017
278
0.110
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.110
 Why?
Histocompatibility Antigens Class I
2
2005
48
0.110
 Why?
Peptide Fragments
4
2009
203
0.110
 Why?
Endometrial Neoplasms
2
2005
144
0.110
 Why?
Uterine Neoplasms
2
2005
60
0.100
 Why?
Papillomavirus Infections
3
2011
172
0.100
 Why?
Mutation
1
2019
1351
0.100
 Why?
Mice, Inbred C57BL
3
2017
1903
0.100
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
138
0.100
 Why?
Lymphocytes
1
2013
150
0.100
 Why?
Antigens, Viral
3
2007
43
0.090
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.090
 Why?
Killer Cells, Natural
4
2005
116
0.090
 Why?
rho GTP-Binding Proteins
1
2011
8
0.090
 Why?
Clonal Anergy
1
2011
13
0.090
 Why?
A Kinase Anchor Proteins
1
2011
3
0.090
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.090
 Why?
Antigen-Presenting Cells
1
2011
23
0.090
 Why?
Drug Resistance, Neoplasm
5
2017
327
0.090
 Why?
Antigens, Surface
1
2011
47
0.090
 Why?
Human papillomavirus 16
1
2011
44
0.090
 Why?
Antineoplastic Agents, Alkylating
1
2011
77
0.090
 Why?
Immunity, Cellular
2
2008
64
0.090
 Why?
Uterine Cervical Dysplasia
1
2011
51
0.090
 Why?
Cyclophosphamide
1
2011
171
0.090
 Why?
Prostate
1
2011
117
0.090
 Why?
Diphosphonates
1
2011
92
0.090
 Why?
Imidazoles
1
2011
124
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2011
858
0.080
 Why?
Papillomaviridae
3
2005
105
0.080
 Why?
Phenotype
1
2013
799
0.080
 Why?
Neoplasm Staging
3
2007
770
0.080
 Why?
Gene Expression Profiling
2
2005
1110
0.080
 Why?
K562 Cells
2
2008
41
0.080
 Why?
Carrier Proteins
1
2011
326
0.080
 Why?
Tumor Microenvironment
2
2023
255
0.080
 Why?
CA-125 Antigen
1
2008
16
0.080
 Why?
Immediate-Early Proteins
1
2008
18
0.080
 Why?
Cytomegalovirus
1
2008
30
0.070
 Why?
Green Fluorescent Proteins
1
2008
89
0.070
 Why?
RNA, Messenger
4
2005
1142
0.070
 Why?
Interleukin-4
2
2005
44
0.070
 Why?
Antibody Formation
1
2007
51
0.070
 Why?
Prostatic Neoplasms
1
2011
400
0.070
 Why?
Antibodies, Viral
1
2007
110
0.070
 Why?
Amino Acid Sequence
2
2005
591
0.070
 Why?
RNA Interference
2
2017
186
0.070
 Why?
Molecular Sequence Data
2
2005
792
0.070
 Why?
Ovary
3
2017
107
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.060
 Why?
Recombinant Proteins
1
2007
491
0.060
 Why?
Hypersensitivity, Delayed
1
2005
18
0.060
 Why?
Breast Neoplasms
3
2003
1206
0.060
 Why?
Monocytes
2
2022
130
0.060
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.060
 Why?
Electroporation
1
2005
18
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Cell Line
4
2010
1045
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Gene Transfer Techniques
1
2005
40
0.060
 Why?
Interleukin-12
1
2005
27
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
583
0.060
 Why?
Immunologic Memory
1
2005
32
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Plasmodium falciparum
1
2005
23
0.060
 Why?
Burkitt Lymphoma
1
2005
27
0.060
 Why?
Endemic Diseases
1
2005
25
0.060
 Why?
Malaria, Falciparum
1
2005
21
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
33
0.060
 Why?
Gangliosides
1
2004
5
0.060
 Why?
Ascitic Fluid
1
2004
13
0.060
 Why?
Proteins
2
2005
354
0.060
 Why?
Genetic Therapy
1
2005
120
0.060
 Why?
Ovariectomy
1
2004
113
0.060
 Why?
Vaccines, Subunit
1
2004
15
0.060
 Why?
Hysterectomy
1
2004
90
0.050
 Why?
Immunization, Passive
1
2004
29
0.050
 Why?
Interleukin-6
1
2005
278
0.050
 Why?
Clinical Trials as Topic
2
2007
468
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2019
397
0.050
 Why?
Cell Differentiation
2
2004
674
0.050
 Why?
Protein Binding
1
2005
680
0.050
 Why?
Epithelial Cells
1
2005
215
0.050
 Why?
Vesiculovirus
1
2022
6
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Virus Latency
1
2003
53
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Adhesion Molecules
1
2003
87
0.050
 Why?
Cell Communication
1
2003
72
0.050
 Why?
Nucleotidyltransferases
1
2022
15
0.050
 Why?
Mammals
1
2022
62
0.050
 Why?
Disease Models, Animal
2
2022
1484
0.050
 Why?
Tumor Cells, Cultured
4
2003
456
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
222
0.050
 Why?
Rabbits
1
2022
374
0.050
 Why?
Down-Regulation
1
2003
347
0.050
 Why?
Blood Transfusion
1
2002
128
0.050
 Why?
Radiotherapy
1
2002
129
0.050
 Why?
Disease Progression
2
2019
870
0.050
 Why?
Viral Proteins
1
2022
164
0.040
 Why?
Immunohistochemistry
4
2005
985
0.040
 Why?
Carcinoma, Squamous Cell
1
2004
332
0.040
 Why?
Endothelium
1
2019
38
0.040
 Why?
Transcriptome
1
2022
367
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
62
0.040
 Why?
Gene Expression
3
2008
623
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
1031
0.040
 Why?
Injections, Intraperitoneal
2
2010
57
0.040
 Why?
Tissue Banks
1
2017
9
0.040
 Why?
Mice, Inbred NOD
1
2017
92
0.030
 Why?
STAT3 Transcription Factor
1
2017
88
0.030
 Why?
Antibodies, Monoclonal, Humanized
3
2004
236
0.030
 Why?
Glycosylation
1
2017
106
0.030
 Why?
Tumor Burden
1
2017
136
0.030
 Why?
RNA, Small Interfering
1
2017
218
0.030
 Why?
Multiple Myeloma
1
2011
3049
0.030
 Why?
Protein Processing, Post-Translational
1
2017
158
0.030
 Why?
Kaplan-Meier Estimate
1
2017
484
0.030
 Why?
Lung Neoplasms
1
2002
636
0.030
 Why?
Survival Analysis
2
2010
671
0.030
 Why?
Apoptosis
2
2014
1127
0.030
 Why?
Perforin
2
2005
12
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
11
0.030
 Why?
Neovascularization, Pathologic
1
2014
158
0.030
 Why?
Anti-Bacterial Agents
1
2019
801
0.030
 Why?
Interleukin-2
2
2003
69
0.030
 Why?
Membrane Glycoproteins
2
2005
244
0.020
 Why?
Vaginal Smears
1
2011
28
0.020
 Why?
Organ Specificity
1
2011
117
0.020
 Why?
Prostate-Specific Antigen
1
2011
44
0.020
 Why?
DNA, Viral
1
2011
138
0.020
 Why?
Time Factors
2
2010
2957
0.020
 Why?
Major Histocompatibility Complex
1
2010
13
0.020
 Why?
Prognosis
2
2005
2094
0.020
 Why?
Transduction, Genetic
1
2008
44
0.020
 Why?
Fluorescent Antibody Technique
1
2008
111
0.020
 Why?
Leukocytes, Mononuclear
1
2008
122
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
T-Lymphocyte Subsets
1
2007
41
0.020
 Why?
Models, Immunological
1
2007
8
0.020
 Why?
Aged, 80 and over
2
2005
3391
0.020
 Why?
Immune Tolerance
1
2007
91
0.020
 Why?
Adolescent
2
2011
6692
0.020
 Why?
HLA-B Antigens
1
2006
8
0.020
 Why?
Clone Cells
1
2006
77
0.020
 Why?
Immunity, Innate
1
2007
117
0.020
 Why?
Male
3
2011
26696
0.020
 Why?
Combined Modality Therapy
1
2007
636
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Mice, Inbred C3H
1
2005
83
0.010
 Why?
Protein Sorting Signals
1
2005
8
0.010
 Why?
Peptides
1
2006
229
0.010
 Why?
Protein Engineering
1
2005
18
0.010
 Why?
Histocompatibility Antigens Class II
1
2005
35
0.010
 Why?
Plasmids
1
2005
167
0.010
 Why?
Species Specificity
1
2005
192
0.010
 Why?
Mice, SCID
1
2005
182
0.010
 Why?
Protein Folding
1
2005
61
0.010
 Why?
Epithelium
1
2004
65
0.010
 Why?
Endocytosis
1
2005
55
0.010
 Why?
Receptors, Cell Surface
1
2005
113
0.010
 Why?
Carboplatin
1
2004
57
0.010
 Why?
Radiotherapy, Adjuvant
1
2004
63
0.010
 Why?
Paclitaxel
1
2004
90
0.010
 Why?
Polymerase Chain Reaction
1
2005
460
0.010
 Why?
Transfection
1
2005
372
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
53
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
12
0.010
 Why?
Tumor Stem Cell Assay
1
2003
17
0.010
 Why?
Proportional Hazards Models
1
2005
443
0.010
 Why?
Cervix Uteri
1
2004
49
0.010
 Why?
Up-Regulation
1
2005
462
0.010
 Why?
Swine
1
2005
426
0.010
 Why?
Kinetics
1
2005
623
0.010
 Why?
Keratinocytes
1
2004
93
0.010
 Why?
Receptors, Interleukin-2
1
2002
7
0.010
 Why?
Lymphocyte Subsets
1
2002
14
0.010
 Why?
Cell Culture Techniques
1
2003
99
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
55
0.010
 Why?
Antigens, CD19
1
2002
28
0.010
 Why?
Leukocytes
1
2003
61
0.010
 Why?
Receptors, IgG
1
2002
24
0.010
 Why?
Cell Death
1
2003
176
0.010
 Why?
Doxorubicin
1
2004
239
0.010
 Why?
Immunophenotyping
1
2002
117
0.010
 Why?
Cisplatin
1
2004
285
0.010
 Why?
Survival Rate
1
2005
940
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
46
0.010
 Why?
Tumor Virus Infections
1
2002
48
0.010
 Why?
Fatal Outcome
1
2002
196
0.010
 Why?
Young Adult
1
2011
4319
0.010
 Why?
Cell Division
1
2002
291
0.010
 Why?
Case-Control Studies
1
2004
1201
0.010
 Why?
Prospective Studies
1
2004
2428
0.010
 Why?
Risk Factors
1
2004
3872
0.010
 Why?
Antineoplastic Agents
1
2002
1222
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (301) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department